Discover
HRTX
Heron Therapeutics, Inc.
0.31
1 x 0.27
1 x 0.35
bid
ask
-
0.01
1.90%
1 @ 07:30 PM
0.32 +0.01 (3.33%)
| Ytd | -76.18% | |
| 1y | -75.99% |
0.31
day range
0.32
0.30
52 week range
1.49
| Open | 0.32 | Prev Close | 0.32 | Low | 0.31 | High | 0.32 | Mkt Cap | 58.80M |
| Vol | 3.95M | Avg Vol | 2.62M | EPS | -0.19 | P/E | N/A | Forward P/E | 178.00 |
| Beta | 1.81 | Short Ratio | 14.20 | Inst. Own | 81.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 0.39 | 200-d Avg | 0.85 | 1yr Est | 6.00 |
| Income Statement | |||
| Total Revenue | 37.67M | ||
| Revenues (USD) | 37.67M | ||
| Cost of Revenue | 11.57M | ||
| Gross Profit | 26.09M | ||
| Operating Expenses | 28.14M | ||
| Research and Development Expense | 2.70M | ||
| Selling, General and Administrative Expense | 25.44M | ||
| Operating Income | -2.04M | ||
| Net Income | -5.49M | ||
| Net Income Common Stock | -5.49M | ||
| Net Income Common Stock (USD) | -5.49M | ||
| Consolidated Income | -5.49M | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -5.49M | ||
| Earning Before Interest & Taxes (USD) | -5.49M | ||
| Weighted Average Shares | 190.34M | ||
| Weighted Average Shares Diluted | 190.34M | ||
| Balance Sheet | |||
| Cash and Equivalents | 20.72M | ||
| Cash and Equivalents (USD) | 20.72M | ||
| Investments | 21.94M | ||
| Investments Current | 21.94M | ||
| Trade and Non-Trade Receivables | 89.57M | ||
| Current Assets | 229.85M | ||
| Property, Plant & Equipment Net | 17.41M | ||
| Total Assets | 252.26M | ||
| Debt Current | 200.00K | ||
| Total Debt | 148.35M | ||
| Current Liabilities | 92.15M | ||
| Debt Non-Current | 148.15M | ||
| Total Liabilities | 245.35M | ||
| Accumulated Retained Earnings (Deficit) | -1.95B | ||
| Accumulated Other Comprehensive Income | -6.00K | ||
| Shareholders Equity | 6.91M | ||
| Shareholders Equity (USD) | 6.91M | ||
| Assets Non-Current | 22.42M | ||
| Total Debt (USD) | 148.35M | ||
| Inventory | 90.59M | ||
| Liabilities Non-Current | 153.21M | ||
| Trade and Non-Trade Payables | 11.64M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 452.00K | ||
| Net Cash Flow from Financing | 82.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.40M | ||
| Capital Expenditure | -138.00K | ||
| Issuance (Purchase) of Equity Shares | 82.00K | ||
| Net Cash Flow from Investing | -3.26M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.13M | ||
| Net Cash Flow from Operations | -2.21M | ||
| Share Based Compensation | 3.18M | ||